id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S9216 R31979 |
Pennell (Phenytoin), 2012 | Microcephaly at birth (head circumference < 3 percentile) | during pregnancy (anytime or not specified) | prospective cohort | exposed to other treatment, sick | Adjustment: No | 0.98 [0.26;3.69] C | 4/48 6/71 | 10 | 48 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S9202 R31927 |
Holmes (Phenytoin) (Controls unexposed, disease free), 2001 | Microcephaly at birth (Head circumference more than 2 SD below the mean value for the same race, sex and gestational age) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, disease free excluded | Adjustment: No |
0.73 [0.09;5.88] C excluded (control group) |
1/87 8/508 | 9 | 87 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S9203 R31936 |
Holmes (Phenytoin) (Controls unexposed, sick), 2001 | Microcephaly at birth (Head circumference more than 2 SD below the mean value for the same race, sex and gestational age) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: No | 0.55 [0.05;6.14] C | 1/87 2/96 | 3 | 87 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S9254 R32094 |
Battino (Phenytoin), 1999 | Small head circumferences (at birth < 10th percentile) | throughout pregnancy | prospective cohort | unexposed, sick | Adjustment: No | 0.57 [0.13;2.45] C | 6/100 3/30 | 9 | 100 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S9255 R32095 |
Díaz-Romero (Phenytoin), 1999 | Head circumference <2 SD at birth (measured by a physician and correlated with sex and with gestational age) | during pregnancy (anytime or not specified) | cohort | unexposed, sick | Adjustment: No | 0.37 [0.01;20.14] C | 0/21 0/8 | 0 | 21 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S9274 R32159 |
Nulman (Phenytoin) (Controls unexposed, sick) (Mixed indications), 1997 | Microcephaly at unknown age (head circumference ≤ 2 SD from the mean of children of the same age and sex) | at least 1st trimester | prospective cohort | unexposed, sick | Adjustment: No Controls: epilepsy indication | 1.39 [0.06;31.88] C | 2/33 0/9 | 2 | 33 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S9233 R32039 |
Kelly (Phenytoin), 1984 | Microcephaly at unknown age (head circumference < 5th centile) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No | 0.50 [0.03;8.42] C | 1/41 1/21 | 2 | 41 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 6 studies | 0.72 [0.32;1.63] | 26 | 330 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Phenytoin; 2: Phenytoin) (Controls unexposed, sick; 3: Phenytoin; 4: Phenytoin; 5: Phenytoin) (Controls unexposed, sick) (Mixed indications; 6: Phenytoin;
Asymetry test p-value = 0.5353 (by Egger's regression)
slope=-0.0536 (0.4341); intercept=-0.2890 (0.4266); t=0.6774; p=0.5353
excluded 9202